US1354753A
(en)
|
1919-02-11 |
1920-10-05 |
E M Lannes |
Portable building
|
US2180006A
(en)
|
1936-09-09 |
1939-11-14 |
Eastman Kodak Co |
Process for the separation and refining of amines
|
GB891817A
(en)
|
1959-04-07 |
1962-03-21 |
Upjohn Co |
Improvements in or relating to injectable tetracyclic preparations
|
US3843787A
(en)
|
1969-01-15 |
1974-10-22 |
Pierrel Spa |
Water soluble derivative of erythromycin
|
US3668282A
(en)
|
1970-05-08 |
1972-06-06 |
Stauffer Chemical Co |
Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides
|
SE458505B
(sv)
|
1979-07-10 |
1989-04-10 |
Lepetit Spa |
Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
US4474768A
(en)
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
JPS59175414A
(ja)
|
1983-03-23 |
1984-10-04 |
Toyo Jozo Co Ltd |
マクロライド抗生物質の安定な経口用製剤および安定化法
|
US4742049A
(en)
|
1986-06-04 |
1988-05-03 |
Abbott Laboratories |
Semisynthetic erythromycin antibiotics
|
KR960000434B1
(ko)
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
DE3860503D1
(de)
|
1987-09-03 |
1990-10-04 |
Pliva Pharm & Chem Works |
10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
|
BE1001869A3
(fr)
|
1988-10-12 |
1990-04-03 |
Franz Legros |
Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
|
IL99995A
(en)
|
1990-11-21 |
1997-11-20 |
Roussel Uclaf |
Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
|
US5985844A
(en)
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
US5527780A
(en)
|
1992-11-05 |
1996-06-18 |
Roussel Uclaf |
Erythromycin derivatives
|
FR2697524B1
(fr)
|
1992-11-05 |
1994-12-23 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
JPH07126172A
(ja)
*
|
1993-11-05 |
1995-05-16 |
Genichiro Soma |
Lpsを含む抗mrsa剤及び動物用抗mrsa剤
|
FR2718450B1
(fr)
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
FR2719587B1
(fr)
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
FR2739620B1
(fr)
|
1995-10-09 |
1997-12-19 |
Roussel Uclaf |
Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
|
US6274715B1
(en)
|
1995-11-08 |
2001-08-14 |
Abbott Laboratories |
Tricyclic erythromycin derivatives
|
FR2742757B1
(fr)
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2745290B1
(fr)
|
1996-02-28 |
1998-04-03 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
US5719272A
(en)
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
WO1998009978A1
(en)
|
1996-09-04 |
1998-03-12 |
Abbott Laboratories |
6-o-substituted ketolides having antibacterial activity
|
WO1998025895A1
(en)
|
1996-12-13 |
1998-06-18 |
Eli Lilly And Company |
Inhibitors of the enzymatic activity of psa
|
HN1998000086A
(es)
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
WO1998056800A1
(en)
|
1997-06-11 |
1998-12-17 |
Pfizer Products Inc. |
9-oxime erythromycin derivatives
|
US6407074B1
(en)
|
1997-06-11 |
2002-06-18 |
Pfizer Inc |
C-4″-substituted macrolide derivatives
|
HN1998000159A
(es)
|
1997-10-29 |
1999-02-09 |
Monsanto Co |
Derivados de 9- amino - 3 ceto eritromicina
|
IL135792A0
(en)
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
EP1421939B9
(en)
|
1998-03-26 |
2011-03-02 |
Astellas Pharma Inc. |
Sustained release preparation of a macrolide compound like tacrolimus
|
FR2777282B1
(fr)
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
US6020521A
(en)
|
1998-08-26 |
2000-02-01 |
Abbott Laboratories |
Macrolide LHRH antagonists
|
FR2785612A1
(fr)
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
KR100317907B1
(ko)
|
1998-11-24 |
2001-12-24 |
김 완 주 |
신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
|
FR2786188B1
(fr)
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
ATE344269T1
(de)
|
1998-12-10 |
2006-11-15 |
Pfizer Prod Inc |
Carbamat und carbazat ketolid antibiotika
|
ID30233A
(id)
|
1999-01-27 |
2001-11-15 |
Pfizer Prod Inc |
Antibiotika ketolida
|
CA2411293A1
(en)
|
1999-01-28 |
2000-07-28 |
Pfizer Products Inc. |
Novel azalides and methods of making same
|
FR2789392B1
(fr)
|
1999-02-04 |
2001-10-05 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
AR023264A1
(es)
|
1999-04-08 |
2002-09-04 |
Hokuriku Pharmaceutical |
Derivados de eritromicina
|
JP2000351794A
(ja)
|
1999-04-08 |
2000-12-19 |
Hokuriku Seiyaku Co Ltd |
エリスロマイシン誘導体
|
WO2000063225A2
(en)
|
1999-04-16 |
2000-10-26 |
Kosan Biosciences, Inc. |
Macrolide antiinfective agents
|
CN1373767A
(zh)
|
1999-04-16 |
2002-10-09 |
奥索-麦克尼尔药品公司 |
酮式大环内酯抗菌剂
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
US6437106B1
(en)
|
1999-06-24 |
2002-08-20 |
Abbott Laboratories |
Process for preparing 6-o-substituted erythromycin derivatives
|
AU6183700A
(en)
|
1999-08-06 |
2001-03-05 |
Taisho Pharmaceutical Co., Ltd. |
Erythromycin a derivatives
|
US6096922A
(en)
|
1999-11-01 |
2000-08-01 |
Air Products And Chemicals, Inc. |
Process for the synthesis of dialkyl, diaryl, and arylalkyl aminosulfur trifluorides
|
KR100336447B1
(ko)
|
1999-11-24 |
2002-05-15 |
민경윤 |
클라리스로마이신의 개선된 제조방법
|
JP2001261694A
(ja)
|
2000-03-06 |
2001-09-26 |
Pfizer Prod Inc |
ケトライド抗生物質
|
DE60111438T2
(de)
|
2000-03-15 |
2006-05-18 |
Hanmi Pharm. Co., Ltd. |
Verfahren zur Herstellung von einer kristallinen Form II von Clarythromycin
|
NZ523693A
(en)
*
|
2000-07-10 |
2004-08-27 |
Chiron Corp |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
US20020115621A1
(en)
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
GB0031312D0
(en)
|
2000-12-21 |
2001-02-07 |
Glaxo Group Ltd |
Macrolides
|
US7138419B2
(en)
*
|
2000-12-27 |
2006-11-21 |
Corus Pharma, Inc. |
Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
|
JP2004534763A
(ja)
*
|
2001-05-18 |
2004-11-18 |
カイロン コーポレイション |
アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物
|
EP1404693A2
(en)
|
2001-07-03 |
2004-04-07 |
Chiron Corporation |
C12 modified erythromycin macrolides and ketolides having antibacterial activity
|
US20030176327A1
(en)
|
2001-10-25 |
2003-09-18 |
Cassell Gail Houston |
Antibiotics for treating biohazardous bacterial agents
|
CA2477049A1
(en)
|
2002-02-22 |
2003-09-04 |
Pharmacia Corporation |
Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
|
ES2346646T5
(es)
|
2002-05-30 |
2018-02-15 |
The Scripps Research Institute |
Ligación catalizada con cobre de azidas y acetilenos
|
WO2003105775A2
(en)
|
2002-06-17 |
2003-12-24 |
Epigenesis Pharmaceuticals, Inc. |
Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
|
JP4790263B2
(ja)
|
2002-07-08 |
2011-10-12 |
グラクソ グループ リミテッド |
炎症性の疾患および病態を治療する新規な化合物、組成物および方法
|
TW200420573A
(en)
|
2002-09-26 |
2004-10-16 |
Rib X Pharmaceuticals Inc |
Bifunctional heterocyclic compounds and methods of making and using same
|
ITMI20022292A1
(it)
|
2002-10-29 |
2004-04-30 |
Zambon Spa |
9a-azalidi ad attivita' antiinfiammatoria.
|
EP3738591A3
(en)
*
|
2003-03-10 |
2021-03-24 |
Merck Sharp & Dohme Corp. |
Novel antibacterial agents
|
WO2004096822A2
(en)
|
2003-04-25 |
2004-11-11 |
Chiron Corporation |
Pyridyl substituted ketolide antibiotics
|
CA2523541A1
(en)
|
2003-04-25 |
2004-11-11 |
Chiron Corporation |
Novel ketolide derivatives
|
CA2525455A1
(en)
|
2003-05-13 |
2004-11-25 |
Glaxo Group Limited |
Novel 14 and 15 membered-ring compounds
|
WO2005007143A2
(en)
|
2003-07-14 |
2005-01-27 |
The Board Of Trustees Of The University Of Illinois |
Use of makrolides and ketolides for the treatment of tuberculosis
|
US7457520B2
(en)
|
2003-07-24 |
2008-11-25 |
Time Warner Cable, Inc. |
Technique for providing a virtual digital video recorder service through a communications network
|
GB0402578D0
(en)
|
2004-02-05 |
2004-03-10 |
Cambridge Theranostics Ltd |
Methods of treatment of atherosclerosis
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
US20060116336A1
(en)
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
DE602005002475T2
(de)
|
2004-04-28 |
2008-05-29 |
Alembic Ltd., Vadodara |
Verfahren zur vorbereitung von telithromycin
|
RU2006143051A
(ru)
|
2004-05-06 |
2008-06-20 |
Глаксосмитклайн Инстраживацки Центар Загреб Д.О.О. (Hr) |
Сложноэфирные производные макролидов, применение для лечения микробных инфекций
|
WO2006080954A1
(en)
|
2004-07-28 |
2006-08-03 |
Ranbaxy Laboratories Limited |
Ketolide derivatives as antibacterial agents
|
US20060076536A1
(en)
|
2004-09-29 |
2006-04-13 |
Barshied Scott R |
Oxygen scavenging pharmaceutical package and methods for making same
|
GB0424959D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
GB0424958D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
ATE477805T1
(de)
|
2005-01-14 |
2010-09-15 |
Glaxosmithkline Zagreb |
9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
|
WO2006087642A2
(en)
|
2005-01-14 |
2006-08-24 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity
|
EP1836212B1
(en)
|
2005-01-14 |
2011-09-07 |
Glaxo Group Limited |
Macrolide compounds containing biotin and photo-affinity group for macrolide target identification
|
EP1868434A4
(en)
|
2005-03-22 |
2011-10-26 |
Azevan Pharmaceuticals Inc |
BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS
|
US20070015719A1
(en)
|
2005-07-07 |
2007-01-18 |
Elan Pharma International Limited |
Nanoparticulate clarithromycin formulations
|
CA2615813C
(en)
|
2005-07-19 |
2015-12-15 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
|
US8933063B2
(en)
|
2005-10-31 |
2015-01-13 |
Leo Pharma A/S |
Preparation of a crystalline antibiotic substance
|
GB0522715D0
(en)
|
2005-11-08 |
2005-12-14 |
Helperby Therapeutics Ltd |
New use
|
WO2007059307A2
(en)
|
2005-11-15 |
2007-05-24 |
Teva Pharmaceutical Industries Ltd. |
Crystalline and amorphous forms of telithromycin
|
EP1954294A2
(en)
|
2005-11-23 |
2008-08-13 |
Ranbaxy Laboratories Limited |
Use of macrolide derivatives for treating acne
|
US20090005325A1
(en)
|
2005-11-23 |
2009-01-01 |
Biswajit Bas |
Ketolide Derivatives as Antibacterial Agents
|
DOP2006000268A
(es)
|
2005-12-22 |
2007-07-31 |
Pfizer Prod Inc |
Agentes antibacterianos
|
CN101045063B
(zh)
|
2006-03-28 |
2011-01-26 |
广州朗圣药业有限公司 |
注射用克拉霉素水溶性制剂
|
CN103193840A
(zh)
|
2006-05-01 |
2013-07-10 |
大正制药株式会社 |
大环内酯衍生物
|
AU2007256844A1
(en)
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
CN101129383B
(zh)
|
2006-08-25 |
2014-04-02 |
天津和美生物技术有限公司 |
含氨基糖苷类抗生素的抗生素复方
|
AU2008316830B2
(en)
|
2007-10-25 |
2016-03-17 |
Cempra Pharmaceuticals, Inc. |
Process for the preparation of macrolide antibacterial agents
|
US20090209547A1
(en)
|
2008-02-15 |
2009-08-20 |
In Jong Kim |
C-8 halogenated macrolides
|
EP2362727B1
(en)
|
2008-10-24 |
2018-04-11 |
Cempra Pharmaceuticals, Inc. |
Methods for treating resistant diseases using triazole containing macrolides
|
NZ596245A
(en)
*
|
2009-04-24 |
2013-11-29 |
Mpex Pharmaceuticals Inc |
Methods of treating a pulmonary bacterial infection using fluoroquinolones
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
CA2767614C
(en)
|
2009-07-13 |
2019-01-15 |
Cempra Pharmaceuticals Inc. |
Fusidic acid dosing regimens for treatment of bacterial infections
|
CN102724874B
(zh)
*
|
2009-09-10 |
2018-06-01 |
森普拉制药公司 |
治疗疟疾、结核病和mac疾病的方法
|
US20110119604A1
(en)
|
2009-11-19 |
2011-05-19 |
Clevest Solutions Inc. |
System and method for a configurable and extensible allocation and scheduling tool
|
CN109091489A
(zh)
*
|
2010-03-10 |
2018-12-28 |
森普拉制药公司 |
大环内酯类抗生素的肠胃外制剂
|
MY162411A
(en)
|
2010-03-22 |
2017-06-15 |
Cempra Pharmaceuticals Inc |
Crystalline forms of a macrolide, and uses therefor
|
SI2571506T1
(sl)
|
2010-05-20 |
2017-12-29 |
Cempra Pharmaceuticals, Inc. |
Postopki za pripravo makrolidov in ketolidov ter njihovih intermediatov
|
US8247394B2
(en)
|
2010-06-02 |
2012-08-21 |
Cempra Pharmaceuticals Inc. |
Methods of treating urethritis and related infections using fusidic acid
|
US9260473B2
(en)
|
2010-07-19 |
2016-02-16 |
Virginia Commonwealth University |
Bivalent multifunctional ligands targeting Aβ oligomers as treatment for Alzheimer's disease
|
CA2812044A1
(en)
|
2010-08-30 |
2012-03-08 |
Cempra Pharmaceuticals Inc. |
Methods of treating bacterial infections through pulmonary delivery of fusidic acid
|
WO2012034058A1
(en)
|
2010-09-10 |
2012-03-15 |
Cempra Pharmaceuticals, Inc. |
Hydrogen bond forming fluoro ketolides for treating diseases
|
WO2012042534A2
(en)
|
2010-09-28 |
2012-04-05 |
Glenmark Generics Limited |
Processes for the preparation of r-sitagliptin and intermediates thereof
|
WO2012162439A2
(en)
|
2011-05-23 |
2012-11-29 |
Cem-102 Pharmaceuticals, Inc. |
Compositions comprising fusidic acid and packages therefor
|
MX2014000540A
(es)
*
|
2011-07-12 |
2014-05-01 |
Cardeas Pharma Corp |
Formulaciones de combinaciones de amecacina y forsfomicina y metodos y sistemas para el tratamiento de neumonia asociada a ventilacion mecanica (vap) y traqueobronquitis asociada a ventilacion mecanica (vat).
|
PT2748165T
(pt)
|
2011-08-27 |
2016-12-28 |
Wockhardt Ltd |
Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona e sua utilização no tratamento de infeções bacterianas
|
TW201311663A
(zh)
|
2011-08-29 |
2013-03-16 |
Infinity Pharmaceuticals Inc |
雜環化合物及其用途
|
US8461188B2
(en)
|
2011-10-20 |
2013-06-11 |
Trius Therapeutics, Inc. |
Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
|
JP6208742B2
(ja)
|
2012-03-27 |
2017-10-04 |
センプラ ファーマシューティカルズ,インコーポレイテッド |
マクロライド抗生物質を投与するための非経口製剤
|
WO2014152326A1
(en)
|
2013-03-14 |
2014-09-25 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
US9751908B2
(en)
|
2013-03-15 |
2017-09-05 |
Cempra Pharmaceuticals, Inc. |
Convergent processes for preparing macrolide antibacterial agents
|
JP6437523B2
(ja)
|
2013-04-04 |
2018-12-12 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
マクロライドならびにそれらの調製および使用の方法
|
WO2015123256A1
(en)
|
2014-02-14 |
2015-08-20 |
Cempra Pharmaceuticals, Inc. |
Compositions and methods for treating diabetes and liver diseases
|
CN106660945A
(zh)
|
2014-05-27 |
2017-05-10 |
迪法玛弗朗西斯有限公司 |
叠氮基烷基胺盐及其作为中间体的用途
|
KR20170039689A
(ko)
|
2014-08-05 |
2017-04-11 |
셈프라 파마슈티컬스, 인크. |
항균제의 분말 경구 현탁제 제형
|
JP6773672B2
(ja)
|
2015-03-06 |
2020-10-21 |
センプラ ファーマシューティカルズ,インコーポレイテッド |
フルオロケトライドを調製するための方法
|